Number of results to display per page
Search Results
1442. Filosofská historie
- Creator:
- Alois Jirásek
- Publisher:
- Kruh přátel československé knihy
- Format:
- print, text, regular print, and 127 s. ; 19 cm
- Type:
- text, volume, short story, české novely, historické novely, model:monograph, and TEXT
- Subject:
- Česká próza, 1801-1850, dějiny, Litomyšl (Česko), 821.162.3-32, 94(437.314), (0:82-321.6), 908(437.1)Litomyšl(091), 25, and 821.162.3-3
- Language:
- Czech
- Description:
- Alois Jirásek
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1443. Filosofská historie
- Creator:
- Alois Jirásek and Adolf Kašpar
- Publisher:
- Šolc a Šimáček
- Format:
- print, text, regular print, and 204 s. : il. ; 22 cm
- Type:
- text, volume, short story, české novely, historické novely, model:monograph, and TEXT
- Subject:
- Česká próza, 1801-1850, dějiny, Litomyšl (Česko), 821.162.3-32, 94(437.314), (0:82-321.6), 908(437.1)Litomyšl(091), 25, and 821.162.3-3
- Language:
- Czech
- Description:
- Alois Jirásek ; ilustroval Adolf Kašpar
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1444. Filosofská historie
- Creator:
- Alois Jirásek and Adolf Kašpar
- Publisher:
- J. Otto
- Format:
- print, text, regular print, and 204 s. : il. ; 22 cm
- Type:
- text, volume, novel, české romány, model:monograph, and TEXT
- Subject:
- Česká próza, 821.162.3-31, (0:82-31), 25, and 821.162.3-3
- Language:
- Czech
- Description:
- Alois Jirásek ; ilustroval Adolf Kašpar
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1445. Filosofska historija: powědańčko
- Creator:
- Alois Jirásek
- Publisher:
- Koło serbskich spisowaćelow
- Format:
- print, text, regular print, and xii, 130 s. ; 17 cm
- Type:
- text, volume, short story, české novely, historické novely, model:monograph, and TEXT
- Subject:
- Česká próza, 1801-1850, dějiny, Litomyšl (Česko), 821.162.3-32, 94(437.314), (0:82-321.6), 908(437.1)Litomyšl(091), 25, and 821.162.3-3
- Language:
- Czech
- Description:
- Alois Jirásek ; přełožił Jurij Wićaz and Přeloženo z češtiny
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1446. Filozofska historija
- Creator:
- Alois Jirásek and Jindřich Procházka
- Publisher:
- J. Herejk
- Format:
- print, text, regular print, and 142 s. ; 20 cm
- Type:
- text, volume, short story, české novely, historické novely, model:monograph, and TEXT
- Subject:
- Česká próza, 1801-1850, dějiny, Litomyšl (Česko), 821.162.3-32, 94(437.314), (0:82-321.6), 908(437.1)Litomyšl(091), 25, and 821.162.3-3
- Language:
- Czech
- Description:
- Alois Jirásek ; preveo Jindra Procházka and Přeloženo z češtiny
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1447. Financial policy of Czechoslovakia during the first year of its history
- Creator:
- Alois Rašín
- Publisher:
- Clarendon Press
- Format:
- print, text, regular print, and 160 s. : il. ; 25 cm
- Type:
- text, volume, monografie, monographs, model:monograph, and TEXT
- Subject:
- Veřejné finance, 1918-1930, 1918-1923, finanční politika, Československo, financial policy, Czechoslovakia, 336.02, (437), (048.8), 4, and 336.1/.5
- Language:
- English and Czech
- Description:
- by Alois Rašín, Přeloženo z češtiny, and Obsahuje rejstřík
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1448. First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study
- Creator:
- Díaz-Rubio, Eduardo, Gómez-Españ, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Abad, Albert, Valladares, Manuel, Rivera, Fernando, Safont, Maria J., Martínez De Prado, Purificación, Gallén, Manuel, González, Encarnación, Marcuello, Eugenio, Benavides, Manuel, Carlos Fernández-Martos, Losa, Ferrán, Escudero, Pilar, Arrivi, Antonio, Cervantes, Andrés, Dueñ, Rosario, López-Ladrón, Amelia, Llanos, Marta, Tabernero, Jose M., Antón, Antonio, and Aranda, Enrique
- Format:
- braille, text, and regular print
- Type:
- model:article, article, Text, přehledy, and TEXT
- Subject:
- kolorektální nádory--farmakoterapie--sekundární, protokoly antitumorózní kombinované chemoterapie--terapeutické užití, deoxycytidin--analogy a deriváty--aplikace a dávkování--terapeutické užití, fluorouracil--analogy a deriváty--aplikace a dávkování--terapeutické užití, organoplatinové sloučeniny--aplikace a dávkování--terapeutické užití, monoklonální protilátky--aplikace a dávkování--terapeutické užití, přežití po terapii bez příznaků nemoci, analýza přežití, nežádoucí účinky léčiv, statistika jako téma, multicentrické studie jako téma, klinické zkoušky, fáze III - jako téma, lidé, and financování organizované
- Language:
- Czech and English
- Description:
- Disclosures: Eduardo Díaz-Rubio: Roche (C/A, RF); Auxiliadora Gómez-España: None; Bartomeu Massutí: Roche (C/A); Javier Sastre: None; Albert Abad: Roche (C/A); Manuel Valladares: Roche (C/A, RF, H); Fernando Rivera: Roche (C/A, RF); Maria J. Safont: None; Purificación Martínez de Prado: None; Manuel Gallén: None; Encarnación González: None; Eugenio Marcuello: None; Manuel Benavides: Roche (C/A); Carlos Fernández-Martos: None; Ferrán Losa: None; Pilar Escudero: None; Antonio Arrivi: None; Andrés Cervantes: Roche (H); Rosario Dueñas: None; Amelia López-Ladrón: None; Adelaida Lacasta: None; Marta Llanos: None; Jose M. Tabernero: Roche, Genentech, Sanofi- Aventis (C/A); Antonio Antón: None; Enrique Aranda: Roche, Merck Serono (C/A). (C/A) Consulting/advisory relationship; (RF) Research funding; (E) Employment; (H) Honoraria received; (OI) Ownership interests; (IP) Intellectual property rights/inventor/patent holder; (SAB) Scientific advisory board. Purpose: The aim of this phase III trial was to compare the efficacy and safety of bevacizumab alone with those of bevacizumab and capecitabine plus oxaliplatin (XELOX) as maintenance treatment following induction chemotherapy with XELOX plus bevacizumab in the first-line treatment of patients with metastatic colorectal cancer (mCRC). Patients and Methods: Patients were randomly assigned to receive six cycles of bevacizumab, capecitabine, and oxaliplatin every 3 weeks followed by XELOX plus bevacizumab or bevacizumab alone until progression. The primary endpoint was the progression-free survival (PFS) interval; secondary endpoints were the overall survival (OS) time, objective response rate (RR), time to response, duration of response, and safety. Results: The intent-to-treat population comprised 480 patients (XELOX plus bevacizumab, n = 239; bevacizumab, n = 241); there were no significant differences in baseline characteristics. The median follow-up was 29.0 months (range, 0–53.2 months). There were no statistically significant differences in the median PFS or OS times or in the RR between the two arms. The most common grade 3 or 4 toxicities in the XELOX plus bevacizumab versus bevacizumab arms were diarrhea, hand–foot syndrome, and neuropathy. Conclusion: Although the noninferiority of bevacizumab versus XELOX plus bevacizumab cannot be confirmed, we can reliably exclude a median PFS detriment >3 weeks. This study suggests that maintenance therapy with singleagent bevacizumab may be an appropriate option following induction XELOX plus bevacizumab in mCRC patients., Eduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, Javier Sastre, Albert Abad, Manuel Valladares, Fernando Rivera, Maria J.Safont, Purificación Martínez De Prado, Manuel Gallén, Encarnación González, Eugenio Marcuello, Manuel Benavides, Carlos Fernández-Martos, Ferrán Losa, Pilar Escudero, Antonio Arrivi, Andrés Cervantes, Rosario Dueñas, Amelia López-Ladrón, Adelaida Lacasta, Marta Llanos, Jose M. Tabernero, Antonio Antón, Enrique Aranda, and Literatura 29
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1449. Fischfang im Böhmerwald
- Publisher:
- s.n.
- Format:
- regular print and 29 s. : mapa
- Type:
- model:monograph, text, and TEXT
- Subject:
- udc:(437.31-13), udc:(437.3), udc:639.21, udc:(282.243.31), udc:(049), sladkovodní rybářství, Vltava (Česko : řeka), Šumava (pohoří : oblast), pojednání, and České Budějovice (Česko)
- Language:
- German
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public
1450. Five roots pattern of median nerve formation
- Creator:
- Natsis, Konstantinos, Paraskevas, George, and Tzika, Maria
- Format:
- print, text, and regular print
- Type:
- model:article, article, Text, kazuistiky, časopisecké články, and TEXT
- Subject:
- staří, arteria brachialis--abnormality, plexus brachialis--abnormality, mrtvola, disekce, předloktí--inervace, lidé, mužské pohlaví, nervus medianus--abnormality, and kosterní svaly--inervace
- Language:
- English
- Description:
- An unusual combination of median nerve's variations has been encountered in a male cadaver during routine educational dissection. In particular, the median nerve was formed by five roots; three roots originated from the lateral cord of the brachial plexus joined individually the median nerve's medial root. The latter (fourth) root was united with the lateral (fifth) root of the median nerve forming the median nerve distally in the upper arm and not the axilla as usually. In addition, the median nerve was situated medial to the brachial artery. We review comprehensively the relevant variants, their embryologic development and their potential clinical applications. and K. Natsis, G. Paraskevas, M. Tzika
- Rights:
- http://creativecommons.org/publicdomain/mark/1.0/ and policy:public